Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 17, 2022

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2027

Conditions
Non Small Cell Lung Cancer Stage IIINeoadjuvant Treatment
Trial Locations (20)

14004

RECRUITING

Hospital Universitario Reina Sofia, Córdoba

15006

RECRUITING

Hospital Universitario De A Coruna, A Coruña

17007

RECRUITING

ICO Girona, Hospital Josep Trueta, Girona

23007

RECRUITING

Hospital Universitario de Jaén, Jaén

27003

RECRUITING

Hospital Universitario Lucus Augusti, Lugo

28040

RECRUITING

Hospital Clínico San Carlos, Madrid

RECRUITING

Hospital Universitario Fundación Jiménez Díaz, Madrid

28046

RECRUITING

Hospital Universitario la Paz, Madrid

28222

RECRUITING

Hospital Universitario Puerta de Hierro, Majadahonda

29010

RECRUITING

Hospital Universitario Regional de Málaga, Málaga

31008

RECRUITING

Complejo Hospitalario de Navarra, Pamplona

46010

RECRUITING

Hospital Clínico de Valencia, Valencia

46026

RECRUITING

Hospital Universitario La Fe, Valencia

47003

RECRUITING

Hospital Clínico Universitario de Valladolid, Valladolid

48013

RECRUITING

Hospital De Basurto, Bilbao

08916

RECRUITING

Hospital Germans Trias I Pujol, Badalona

03010

RECRUITING

Hospital General Universitario de Alicante, Alicante

08028

RECRUITING

Hospital Universitari Quiron Dexeus, Barcelona

08035

RECRUITING

Hospital Universitari Vall d' Hebron, Barcelona

07198

RECRUITING

Hospital Universitari Son Llatzer, Palma de Mallorca

All Listed Sponsors
lead

Fundación GECP

OTHER